Report calls for first-in-man drug trial reforms
A new report has been released this week calling for reforms in first-in-man clinical trials in the wake of the TGN1412 drug trial disaster in London last year.
Archives for March 13, 2007
Mobile phones call up counterfeits
A twist on an existing security technology will use enhanced mobile phones to help establish the authenticity of pharmaceutical products in developing countries.
Micro-jets for painless needle-free injections
Novel needle-free injections that don't cause the pain and bruising common with existing needle-free devices have been developed by a team in California.
Lawsuit looms for Parexel over drug trial disaster
Legal action could begin today against Parexel if the firm does not come up with "an adequate proposal" to compensate the victims of last years drug trial disaster in Northwick Park, London.
BMS extends large Lonza deal
Bristol-Myers Squibb (BMS) has extended its large contract manufacturing arrangement with Lonza by four years.
Shire looking to buy more US biomanufacturing space
With a new drug on the market and its Massachusetts plant at capacity, British drug maker Shire is actively looking to buy more biomanufacturing space in the US.
Patheon on the road to recovery
Patheon has managed to reduce its first-quarter loss as the company cut jobs and took steps to resolve issues at its troubled Puerto Rico plant.